Internet Explorer Alert

It appears you are using Internet Explorer as your web browser. Please note, Internet Explorer is no longer up-to-date and can cause problems in how this website functions
This site functions best using the latest versions of any of the following browsers: Edge, Firefox, Chrome, Opera, or Safari.
You can find the latest versions of these browsers at https://browsehappy.com

Nelson's Neonatal Antimicrobial Therapy, 2nd Edition [Paperback]

Editors in chief: Joseph B. Cantey, MD and Jason Sauberan, PharmD; Contributing editors: Elizabeth D. Barnett, MD; John S. Bradley, MD; David W. Kimberlin, MD; Paul E. Palumbo, MD; J. Howard Smart, MD; William J. Steinbach, MD

Price: $28.95
Member Price: $23.95

The amount must be greater than 0

Description

Completely updated and revised, Nelson’s Neonatal Antimicrobial Therapy, 2nd Edition, provides the most current, practical, and evidence-based recommendations for health care professionals treating neonates. Developed by leading experts in antimicrobial therapy, this resource aims to help clinicians select the right drug, dose, and duration for the treatment of bacterial, viral, fungal, and parasitic infections in neonates.

Neonatal infectious disease therapeutics research continues to expand and respond to emerging novel pathogens and bacterial resistance. The recommendations in this book are based on the best available evidence to provide those taking care of neonates with the best possible treatment decisions, with updated guidance on dosing for low-birth-weight newborns, drug monographs for commonly prescribed drugs, and antimicrobial stewardship guidance for the nursery.

Details

  • ISBN-13: 978-1-61002-698-7
  • Product Code: MA1121
  • Publication Date: April 15, 2024
  • Format: Paperback
  • Pages: 92
  • Availability: In Stock

Editor

Joseph B. Cantey, MD

Joseph B. Cantey, MD, is an Assistant Professor of Pediatrics at the University of Texas Health San Antonio. He attended medical school at the Medical University of South Carolina before completing his pediatric residency at Johns Hopkins. He then completed dual fellowships in pediatric infectious diseases and neonatal/perinatal medicine at the University of Texas Southwestern in Dallas, Texas. His research interests include antimicrobial stewardship and responsible prescribing in the nursery setting; infection control and prevention in the nursery setting; and the pathogenesis, diagnosis, treatment, and longitudinal follow-up of congenital and perinatal infections, particularly herpes simplex virus, cytomegalovirus, and syphilis.

Editor

Jason Sauberan, PharmD

Jason Sauberan, PharmD, is research pharmacist, study coordinator, and investigator at the Neonatal Research Institute, Sharp Mary Birch Hospital for Women and Newborns in San Diego, CA. He also performs clinical duties as a neonatal intensive care pharmacist and antibiotic stewardship pharmacist for the Sharp Mary Birch 84-bed level III NICU, and as a pediatric consultant pharmacist at the Helen Bernardy Center for Medically Fragile Children, Rady Children’s Hospital San Diego. His research interests include anti-infection therapy, drugs in breast milk, parenteral nutrition, and medication safety. He serves on the Scientific Advisory Board of Mother to Baby California, and is an assistant clinical professor, UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences.

Editor

John D. Nelson, MD

Dr Nelson is Professor Emeritus of Pediatrics at the University of Texas Southwestern Medical Center and Children's Medical Center, the same institution he started his career back in 1957. At UT Southwestern he established the first formal Pediatric Infectious Disease fellowship program with Dr Kenneth Haltalin and later Dr George McCracken. He also went on to establish the the National Pediatric Infectious Disease Seminar with Dr. McCracken and in1982 they founded the Pediatric Infectious Disease Journal for which they continue as Chief Editors.

In 1975 Dr Nelson produced the first edition of the Pocket Book of Pediatric Antimicrobial Therapy which has gone through 20 biennial editions and is now edited by Dr John Bradley.

Contributing Editor

Elizabeth Barnett, MD

Elizabeth D. Barnett, MD, FAAP is an Associate Editor of the 2024 and 2021 editions of Red Book and was a member on the Committee on Infectious Diseases from 2014-2020. Dr Elizabeth Barnett is Professor of Pediatrics at Boston University School of Medicine and Chief, Section of Pediatric Infectious Diseases in the Department of Pediatrics at Boston Medical Center.  She leads the Refugee Health Assessment Program and the Pediatric Travel Clinic. Her clinical and research interests include vaccines and vaccine safety, refugee and immigrant medicine, travel medicine, and general pediatric infectious diseases.

Contributing Editor

John S. Bradley, MD

Dr. Bradley has been the Director of the Division of Infectious Diseases at Rady Children's Hospital-San Diego since 1988, and is currently Professor and Chief, Division of Infectious Diseases, Department of Pediatrics, University of California, San Diego School of Medicine. He has served on the American Academy of Pediatrics Committee on Infectious Diseases (Red Book Committee) 2004-2010, and the Council of the Pediatric Infectious Diseases Society (PIDS) Council, 2007-2011 where he promoted the development of a PIDS Antimicrobial Stewardship program.

Contributing Editor

David W. Kimberlin, MD, FAAP

David W. Kimberlin, MD, FAAP is the Editor of the 2024 and 2021 editions of AAP Report of the Committee on Infectious Diseases (Red Book). He also was Editor of the 2015 and 2018 editions and was an Associate Editor of the 2012 and 2009 editions and served on the AAP Committee on Infectious Diseases from 2005- 2011.

Dr Kimberlin is the Sergio Stagno, MD. Endowed Chair in Infectious Diseases, Professor and Co-Division Director, Vice Chair for Clinical and Translational Research.

His clinical and research interests include pediatric infectious diseases, antiviral therapeutics in rare diseases with a large unmet medical need, including neonatal herpes simplex virus (HSV) infections, congenital cytomegalovirus (CMV) disease, congenital Zika infection, neonatal and infantile influenza infection, and neonatal enteroviral sepsis syndrome.

Contributing Editor

Paul E. Palumbo, MD

Paul E. Palumbo, MD, is a subspecialist in Pediatric Infectious Diseases at Dartmouth Medical School. He specializes in pediatric HIV and TB disease.

  

Contributing Editor

J. Howard Smart, MD

Dr. Smart has been practicing General Pediatrics in San Diego since 1996, after completing his residency, which included working with Dr. Bradley at Children’s Hospital (now Rady’s). He is head of the Pediatrics department of his multi-specialty group, and teaches in the UCSD residents’ clinic. His involvement with Nelson’s started with a conversation with Dr. Bradley while flying to an AAP conference, discussing his hobby of mobile app development. Dr. Smart has been an app developer since 2011, and brings together the two knowledge domains of computer science and pediatrics in creating the mobile version of Nelson’s.

Contributing Editor

William J. Steinbach, MD

William Steinbach, MD is Professor of Pediatrics, Professor in Molecular Genetics and Microbiology, and Chief of Pediatric Infectious Diseases at Duke University. His expertise is in transplant infectious diseases, specifically in invasive fungal disease in children. He leads an integrated molecular, translational, and clinical research effort toward improving our understanding of invasive fungal disease epidemiology, diagnosis, and treatment.

Nelson's Neonatal Antimicrobial Therapy, 2nd Edition [Paperback]

Price:: 28.95

Feedback Form